Genoway (France) Today
| ALGEN Stock | EUR 3.70 0.08 2.12% |
Performance0 of 100
| Odds Of DistressLess than 36
|
Genoway is selling at 3.70 as of the 27th of November 2024; that is 2.12% down since the beginning of the trading day. The stock's last reported lowest price was 3.65. Genoway has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Genoway are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of May 2024 and ending today, the 27th of November 2024. Click here to learn more.
genOway S.A., a biotechnology company, engages in the development and sale of custom genetically-modified mouse, rat, and cellular models worldwide. The company was founded in 1999 and is based in Lyon, France. GENOWAY operates under Biotechnology classification in France and is traded on Paris Stock Exchange. The company has 8.19 M outstanding shares. More on Genoway
Moving against Genoway Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Genoway Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Genoway's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Genoway or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman of the Board and CEO | Alexandre Fraichard |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Genoway (ALGEN) is traded on Euronext Paris in France and employs 128 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 30.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genoway's market, we take the total number of its shares issued and multiply it by Genoway's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Genoway operates under Biotechnology sector and is part of Health Care industry. The entity has 8.19 M outstanding shares.
Genoway has accumulated about 0 in cash with (561.34 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Check Genoway Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Genoway is €30.77 Million. Genoway retains 13.06 (percent) of its outstanding shares held by insiders and 22.4 (percent) owned by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Genoway Ownership Details
Genoway Risk Profiles
Although Genoway's alpha and beta are two of the key measurements used to evaluate Genoway's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.4 | |||
| Standard Deviation | 1.89 | |||
| Variance | 3.57 | |||
| Risk Adjusted Performance | (0.03) |
Genoway Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Genoway without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Additional Tools for Genoway Stock Analysis
When running Genoway's price analysis, check to measure Genoway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genoway is operating at the current time. Most of Genoway's value examination focuses on studying past and present price action to predict the probability of Genoway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genoway's price. Additionally, you may evaluate how the addition of Genoway to your portfolios can decrease your overall portfolio volatility.